Xencor Quarterly Balance Sheet
NASDAQ: XNCRHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xencor financial position
As of Jun 30, 2026, Xencor reported total assets of $725.0 million, down 17.6% from a year earlier against total liabilities of $221.7 million. Shareholders' equity stood at $503.2 million, or 69.4% of assets. The company held $44.7 million in cash and equivalents against $104.9 million of debt, a net debt position of $60.2 million.
The current ratio (current assets divided by current liabilities) was 6.39, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.21.
Summary generated from market data by MetaCap's automated system. Methodology
Xencor balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 44.66M | 14.17M | 54.07M | 28.29M | 44.44M | 39.67M | 40.88M | 29.03M | 30.77M | 31.03M | 53.79M | 52.73M |
| Receivables | 42.23M | 12.00M | 29.30M | 21.80M | 47.55M | 37.78M | 60.85M | 25.87M | 35.92M | 22.18M | 23.74M | 55.00M |
| Total Current Assets | 523.21M | 482.86M | 599.82M | 518.44M | 513.15M | 521.27M | 577.60M | 589.60M | 568.92M | 574.85M | 635.60M | 571.18M |
| Property, Plant & Equipment | 50.01M | 51.49M | 53.31M | 54.59M | 56.79M | 58.81M | 59.80M | 62.40M | 63.87M | 63.54M | 66.12M | 68.03M |
| Intangible Assets | 6.52M | 7.60M | 8.38M | 9.47M | 11.25M | 13.36M | 18.48M | 17.92M | 18.78M | 18.85M | 18.66M | 18.74M |
| Total Assets | 724.96M | 736.85M | 875.50M | 868.81M | 879.42M | 904.69M | 951.95M | 999.90M | 840.62M | 896.85M | 965.13M | 778.43M |
| Accounts Payable | 12.65M | 7.92M | 10.83M | 9.08M | 18.53M | 16.19M | 16.76M | 18.77M | 15.84M | 16.01M | 13.91M | 14.97M |
| Short-Term Debt | 27.36M | 26.41M | 43.27M | 45.36M | 50.29M | 52.54M | 48.45M | 44.45M | 38.93M | 34.20M | 27.71M | — |
| Total Current Liabilities | 81.86M | 73.46M | 95.91M | 86.48M | 96.08M | 88.44M | 87.43M | 90.81M | 75.59M | 71.08M | 73.92M | 53.04M |
| Long-Term Debt | 77.54M | 82.12M | 76.48M | 87.78M | 94.74M | 101.84M | 115.16M | 128.34M | 140.83M | 150.90M | 161.77M | — |
| Total Liabilities | 221.73M | 221.21M | 239.91M | 243.50M | 259.07M | 264.81M | 277.92M | 293.98M | 291.90M | 297.12M | 303.05M | 109.42M |
| Shareholders' Equity | 503.23M | 515.63M | 635.59M | 625.32M | 620.35M | 639.87M | 677.61M | 708.86M | 550.50M | 600.07M | 661.75M | 669.01M |
| Retained Earnings | -946.60M | -924.88M | -795.96M | -789.31M | -783.28M | -752.45M | -704.04M | -658.48M | -612.20M | -544.86M | -471.42M | -445.27M |
| Total Debt | 104.89M | 108.53M | 119.75M | 133.14M | 145.02M | 154.38M | 163.61M | 172.79M | 179.76M | 185.10M | 189.48M | — |
| Net Cash (Debt) | -60.23M | -94.36M | -65.68M | -104.85M | -100.58M | -114.70M | -122.73M | -143.76M | -148.99M | -154.06M | -135.69M | 52.73M |
| Shares Outstanding | 74.33M | 74.06M | 71.87M | 71.34M | 71.30M | 71.14M | 70.26M | 69.96M | 61.77M | 61.63M | 61.00M | 60.67M |
This table shows 12 quarterly periods of Xencor's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow XNCR's reporting calendar. What is a balance sheet?